Japan Inspects Mitsubishi Tanabi Drug Plant For Quality Failures
This article was originally published in PharmAsia News
Executive Summary
Japan authorities inspected a plant of a Mitsubishi Tanabi Pharma unit after being told it failed to conduct tests of foreign objects in four drug products. Mitsubishi reported the failure at its wholly-owned Mitsubishi Tanabe Pharma Factory